Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma

  • Arnoud Boot
  • , Nanhai Jiang
  • , Steven G. Rozen*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

A cluster of patients poisoned by herbal medicine in the 1990s revealed that aristolochic acid (AA) causes kidney failure and upper tract urothelial carcinoma (UTUC). Recent research demonstrated that this was not an isolated incident; on the contrary, AA exposure is widespread in East Asia. This editorial highlights research by Lu and colleagues that investigates clinical characteristics of AA and non-AA UTUCs from 90 patients in Beijing based on the AA mutational signature. The study also detected AA mutations in non-tumor tissue of AA exposed patients and showed that AA mutations can be detected in urine, which might form the basis for non-invasive tests for AA exposure.

Original languageEnglish
Pages (from-to)5578-5580
Number of pages3
JournalTheranostics
Volume10
Issue number12
DOIs
StatePublished - 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

Fingerprint

Dive into the research topics of 'Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma'. Together they form a unique fingerprint.

Cite this